This comment was made during the Pitt Hopkins results webinar, on 27 May last year. This approach was said to be based on "competitive reasons".
Since then, Jon has also referred to the need for relevant patents to be in place first, although I suspect that with the two new patent applications filed by the company in October and December, this might have already been achieved.
- Forums
- ASX - By Stock
- Ann: Trofinetide marketing application submitted in Europe
NEU
neuren pharmaceuticals limited
Add to My Watchlist
6.14%
!
$13.31

This comment was made during the Pitt Hopkins results webinar,...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$13.31 |
Change
0.770(6.14%) |
Mkt cap ! $1.655B |
Open | High | Low | Value | Volume |
$12.96 | $14.00 | $12.91 | $19.76M | 1.453M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3000 | $13.30 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.33 | 3716 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3000 | 13.300 |
2 | 10200 | 13.200 |
1 | 2500 | 13.190 |
2 | 1750 | 13.180 |
1 | 50 | 13.170 |
Price($) | Vol. | No. |
---|---|---|
13.330 | 3716 | 1 |
13.370 | 3716 | 1 |
13.390 | 600 | 1 |
13.400 | 3783 | 2 |
13.430 | 3716 | 1 |
Last trade - 16.10pm 26/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
3DA
AMAERO LTD
Hank Holland, Chairman & CEO
Hank Holland
Chairman & CEO
Previous Video
Next Video
SPONSORED BY The Market Online